EU-funded scientists have made key discoveries and developed more effective ways of diagnosing a heart condition that affects millions of Europeans.
Atrial fibrillation (AF) – a condition that causes abnormal heart rhythm – affects up to 2 % of the European population and increases the risk of stroke, heart failure and death. Europe’s ageing population means that the prevalence of AF is expected to increase, which will put further pressure on Europe’s stretched health services.
Read more: cordis.europa.eu